{"id":"ff8b29cd-9e70-4052-a3d3-cec3d0e7ecc0","kind":"companies","code":"UB-C4610","name":"Huma","nameBasis":"source-english","summary":"Web3 PayFi instant liquidity network.","description":"Web3 PayFi network providing instant liquidity and onchain financing for global businesses.","country":"United States","category":null,"originalName":"Huma","eventDate":null,"website":"https://huma.finance/","sourceUpdatedAt":"2026-10-05T00:00:00.000Z","englishUpdatedAt":"2026-10-15T20:33:17.067Z","reviewedAt":"2026-10-15T20:33:17.067Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"164f6e6def3ae1b792861b008448efe89eb8b4d671918b6cbb3a4775f354ce77","companyId":null,"foundedYear":2011,"logoUrl":null,"originalText":"Web3 PayFi即时流动性网络\n\nWeb3 PayFi network providing instant liquidity and onchain financing for global businesses.","sources":[],"related":[{"id":"4f479724-386d-4eea-909c-b01eb45f4fda","kind":"institutions","code":"UB-I5349","name":"AstraZeneca","nameBasis":"original-brand","summary":"AstraZeneca is a company in the United States making strategic investments with industrial capital, investing in the equity of growth-stage and mature companies.","description":"AstraZeneca is a company in the United States making strategic investments with industrial capital, investing in the equity of growth-stage and mature companies.","country":null,"category":null,"originalName":"AstraZeneca","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:28.007Z","englishUpdatedAt":"2026-10-15T18:26:24.845Z","reviewedAt":"2026-10-15T18:26:24.845Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"eb446b300abaac4d78e9ef873e3ae0910304460169b04c6e113243d16fdd2f9a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/astrazeneca"},{"id":"7abed44d-c5e0-4c75-8240-bad977e0041d","kind":"institutions","code":"UB-I9978","name":"HAT","nameBasis":"original-brand","summary":"","description":"","country":null,"category":null,"originalName":"HAT","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:06:11.727Z","englishUpdatedAt":"2026-10-15T18:35:35.108Z","reviewedAt":"2026-10-15T18:35:35.108Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"eb35747f7bce0212423bc22461e6dc00add278399a9c51364abfc021ea8cf73f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hat"},{"id":"91f1a95c-76ae-453e-beef-47e63d99b29a","kind":"news","code":"91f1a95c-76ae-453e-beef-47e63d99b29a","name":"Huma raises USD 80 million in Series D financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Huma完成8000万美元D轮融资","eventDate":"2024-07-17T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:12.744Z","englishUpdatedAt":"2026-10-15T17:19:59.739Z","reviewedAt":"2026-10-15T17:19:59.739Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6e0a2744f87bf5c3807d3d8bfe069df802b034fc0c002d0feea6a1b8c3be14e2","companyId":"ff8b29cd-9e70-4052-a3d3-cec3d0e7ecc0","foundedYear":null,"logoUrl":null,"path":"/news/91f1a95c-76ae-453e-beef-47e63d99b29a"},{"id":"28762dd8-01e3-4bbd-a0f6-6d0a219d5c0b","kind":"news","code":"28762dd8-01e3-4bbd-a0f6-6d0a219d5c0b","name":"Huma reaches USD 17 million in ARR","nameBasis":"translated-title","summary":"On 2025/8/17, X reported that UK telehealth platform Huma disclosed annual recurring revenue of USD 17 million. It provides healthcare institutions with remote patient monitoring.","description":"","country":null,"category":null,"originalName":"Huma ARR达到1700万美元","eventDate":"2025-08-17T00:00:00.000Z","website":"https://x.com/Jackhaldorsson/status/1957024370368393708","sourceUpdatedAt":"2026-10-10T18:59:50.027Z","englishUpdatedAt":"2026-10-15T22:40:43.279Z","reviewedAt":"2026-10-15T22:40:43.279Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"d008c61d48f3e627f2b9ab4f8aa6dbfdd184c7d633c191f3445d3d0120eac5c0","companyId":"ff8b29cd-9e70-4052-a3d3-cec3d0e7ecc0","foundedYear":null,"logoUrl":null,"path":"/news/28762dd8-01e3-4bbd-a0f6-6d0a219d5c0b"},{"id":"ffe4868b-3fad-4891-9916-e5dd7e07e274","kind":"institutions","code":"UB-I5336","name":"拜耳","nameBasis":"transliterated","summary":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","description":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","country":null,"category":null,"originalName":"拜耳","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:56:24.319Z","englishUpdatedAt":"2026-10-15T18:26:25.264Z","reviewedAt":"2026-10-15T18:26:25.264Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5808cdf9b33bb071061d0b8562338a902031ad3ceedcff7d6f67a6b6f44de565","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Baier","path":"/institutions/baier"},{"id":"312897a5-5537-4b6e-a713-26964ffbdfb1","kind":"institutions","code":"UB-I5834","name":"日立创投","nameBasis":"transliterated","summary":"Rili Venture Capital is a Chinese venture capital firm, focused on investment in seed-, startup- and growth-stage startups.","description":"Rili Venture Capital is a Chinese venture capital firm, focused on investment in seed-, startup- and growth-stage startups.","country":null,"category":null,"originalName":"日立创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:28.414Z","englishUpdatedAt":"2026-10-15T18:26:24.780Z","reviewedAt":"2026-10-15T18:26:24.780Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0431c6b00a8c902e1f553d731bb6cc9d14d40fcdd3fc10fc3e3d9b49c0bd15de","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Rili Venture Capital","path":"/institutions/rili-venture-capital"}],"finance":{"funding":{"metric":"funding","count":1,"latest":{"value":80000000,"text":"8000万美元","date":"2024-07-17T00:00:00.000Z","round":"Series D","estimate":"$80M"},"years":[2024],"points":[{"year":2024,"date":"2024-07-17T00:00:00.000Z","round":"Series D","value":80000000,"eventIds":["91f1a95c-76ae-453e-beef-47e63d99b29a"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"91f1a95c-76ae-453e-beef-47e63d99b29a","date":"2024-07-17T00:00:00.000Z","round":"Series D","amountText":"8000万美元","estimateUsd":80000000,"estimateLabel":"$80M","estimateNote":null,"investors":"HAT,拜耳,日立创投,AstraZeneca","institutions":[{"id":"4f479724-386d-4eea-909c-b01eb45f4fda","kind":"institutions","code":"UB-I5349","name":"AstraZeneca","nameBasis":"original-brand","summary":"AstraZeneca is a company in the United States making strategic investments with industrial capital, investing in the equity of growth-stage and mature companies.","description":"AstraZeneca is a company in the United States making strategic investments with industrial capital, investing in the equity of growth-stage and mature companies.","country":null,"category":null,"originalName":"AstraZeneca","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:28.007Z","englishUpdatedAt":"2026-10-15T18:26:24.845Z","reviewedAt":"2026-10-15T18:26:24.845Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"eb446b300abaac4d78e9ef873e3ae0910304460169b04c6e113243d16fdd2f9a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/astrazeneca"},{"id":"7abed44d-c5e0-4c75-8240-bad977e0041d","kind":"institutions","code":"UB-I9978","name":"HAT","nameBasis":"original-brand","summary":"","description":"","country":null,"category":null,"originalName":"HAT","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:06:11.727Z","englishUpdatedAt":"2026-10-15T18:35:35.108Z","reviewedAt":"2026-10-15T18:35:35.108Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"eb35747f7bce0212423bc22461e6dc00add278399a9c51364abfc021ea8cf73f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hat"},{"id":"ffe4868b-3fad-4891-9916-e5dd7e07e274","kind":"institutions","code":"UB-I5336","name":"拜耳","nameBasis":"transliterated","summary":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","description":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","country":null,"category":null,"originalName":"拜耳","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:56:24.319Z","englishUpdatedAt":"2026-10-15T18:26:25.264Z","reviewedAt":"2026-10-15T18:26:25.264Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5808cdf9b33bb071061d0b8562338a902031ad3ceedcff7d6f67a6b6f44de565","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Baier","path":"/institutions/baier"},{"id":"312897a5-5537-4b6e-a713-26964ffbdfb1","kind":"institutions","code":"UB-I5834","name":"日立创投","nameBasis":"transliterated","summary":"Rili Venture Capital is a Chinese venture capital firm, focused on investment in seed-, startup- and growth-stage startups.","description":"Rili Venture Capital is a Chinese venture capital firm, focused on investment in seed-, startup- and growth-stage startups.","country":null,"category":null,"originalName":"日立创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:28.414Z","englishUpdatedAt":"2026-10-15T18:26:24.780Z","reviewedAt":"2026-10-15T18:26:24.780Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0431c6b00a8c902e1f553d731bb6cc9d14d40fcdd3fc10fc3e3d9b49c0bd15de","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Rili Venture Capital","path":"/institutions/rili-venture-capital"}],"newsUrl":null,"evidence":{"headline":"Huma raises USD 80 million in Series D financing","brief":null,"basis":null,"newsPath":"/news/91f1a95c-76ae-453e-beef-47e63d99b29a","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"91f1a95c-76ae-453e-beef-47e63d99b29a","date":"2024-07-17T00:00:00.000Z","round":"Series D","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"HAT,拜耳,日立创投,AstraZeneca","institutions":[{"id":"4f479724-386d-4eea-909c-b01eb45f4fda","kind":"institutions","code":"UB-I5349","name":"AstraZeneca","nameBasis":"original-brand","summary":"AstraZeneca is a company in the United States making strategic investments with industrial capital, investing in the equity of growth-stage and mature companies.","description":"AstraZeneca is a company in the United States making strategic investments with industrial capital, investing in the equity of growth-stage and mature companies.","country":null,"category":null,"originalName":"AstraZeneca","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:28.007Z","englishUpdatedAt":"2026-10-15T18:26:24.845Z","reviewedAt":"2026-10-15T18:26:24.845Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"eb446b300abaac4d78e9ef873e3ae0910304460169b04c6e113243d16fdd2f9a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/astrazeneca"},{"id":"7abed44d-c5e0-4c75-8240-bad977e0041d","kind":"institutions","code":"UB-I9978","name":"HAT","nameBasis":"original-brand","summary":"","description":"","country":null,"category":null,"originalName":"HAT","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:06:11.727Z","englishUpdatedAt":"2026-10-15T18:35:35.108Z","reviewedAt":"2026-10-15T18:35:35.108Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"eb35747f7bce0212423bc22461e6dc00add278399a9c51364abfc021ea8cf73f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hat"},{"id":"ffe4868b-3fad-4891-9916-e5dd7e07e274","kind":"institutions","code":"UB-I5336","name":"拜耳","nameBasis":"transliterated","summary":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","description":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","country":null,"category":null,"originalName":"拜耳","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:56:24.319Z","englishUpdatedAt":"2026-10-15T18:26:25.264Z","reviewedAt":"2026-10-15T18:26:25.264Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5808cdf9b33bb071061d0b8562338a902031ad3ceedcff7d6f67a6b6f44de565","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Baier","path":"/institutions/baier"},{"id":"312897a5-5537-4b6e-a713-26964ffbdfb1","kind":"institutions","code":"UB-I5834","name":"日立创投","nameBasis":"transliterated","summary":"Rili Venture Capital is a Chinese venture capital firm, focused on investment in seed-, startup- and growth-stage startups.","description":"Rili Venture Capital is a Chinese venture capital firm, focused on investment in seed-, startup- and growth-stage startups.","country":null,"category":null,"originalName":"日立创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:28.414Z","englishUpdatedAt":"2026-10-15T18:26:24.780Z","reviewedAt":"2026-10-15T18:26:24.780Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0431c6b00a8c902e1f553d731bb6cc9d14d40fcdd3fc10fc3e3d9b49c0bd15de","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Rili Venture Capital","path":"/institutions/rili-venture-capital"}],"newsUrl":null,"evidence":{"headline":"Huma raises USD 80 million in Series D financing","brief":null,"basis":null,"newsPath":"/news/91f1a95c-76ae-453e-beef-47e63d99b29a","sourceCount":0}}]},"revenue":{"metric":"revenue","count":1,"latest":{"value":17000000,"text":"1700万美元（ARR）","date":"2025-08-17T00:00:00.000Z","round":null,"estimate":"$17M (ARR)"},"years":[2025],"points":[{"year":2025,"date":"2025-08-17T00:00:00.000Z","round":null,"value":17000000,"eventIds":["28762dd8-01e3-4bbd-a0f6-6d0a219d5c0b"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"28762dd8-01e3-4bbd-a0f6-6d0a219d5c0b","date":"2025-08-17T00:00:00.000Z","round":null,"amountText":"1700万美元（ARR）","estimateUsd":17000000,"estimateLabel":"$17M (ARR)","estimateNote":null,"investors":null,"institutions":[],"newsUrl":"https://x.com/Jackhaldorsson/status/1957024370368393708","evidence":{"headline":"Huma reaches USD 17 million in ARR","brief":"On 2025/8/17, X reported that UK telehealth platform Huma disclosed annual recurring revenue of USD 17 million. It provides healthcare institutions with remote patient monitoring.","basis":"translated-source-brief","newsPath":"/news/28762dd8-01e3-4bbd-a0f6-6d0a219d5c0b","sourceCount":1}}]}},"events":[{"id":"28762dd8-01e3-4bbd-a0f6-6d0a219d5c0b","kind":"other","eventDate":"2025-08-17T00:00:00.000Z","revenueDate":"2025-08-17T00:00:00.000Z","round":null,"amountText":null,"valuationText":null,"revenueText":"1700万美元（ARR）","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":17000000,"cumulativeFundingEstimateUsd":null,"investors":null,"newsUrl":"https://x.com/Jackhaldorsson/status/1957024370368393708","newsTypes":["收入"],"institutions":[],"roundName":null,"amountLabel":null,"valuationLabel":null,"revenueLabel":"$17M (ARR)","cumulativeFundingLabel":null},{"id":"91f1a95c-76ae-453e-beef-47e63d99b29a","kind":"funding","eventDate":"2024-07-17T00:00:00.000Z","revenueDate":null,"round":"D轮","amountText":"8000万美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":80000000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"HAT,拜耳,日立创投,AstraZeneca","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"4f479724-386d-4eea-909c-b01eb45f4fda","kind":"institutions","code":"UB-I5349","name":"AstraZeneca","nameBasis":"original-brand","summary":"AstraZeneca is a company in the United States making strategic investments with industrial capital, investing in the equity of growth-stage and mature companies.","description":"AstraZeneca is a company in the United States making strategic investments with industrial capital, investing in the equity of growth-stage and mature companies.","country":null,"category":null,"originalName":"AstraZeneca","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:28.007Z","englishUpdatedAt":"2026-10-15T18:26:24.845Z","reviewedAt":"2026-10-15T18:26:24.845Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"eb446b300abaac4d78e9ef873e3ae0910304460169b04c6e113243d16fdd2f9a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/astrazeneca"},{"id":"7abed44d-c5e0-4c75-8240-bad977e0041d","kind":"institutions","code":"UB-I9978","name":"HAT","nameBasis":"original-brand","summary":"","description":"","country":null,"category":null,"originalName":"HAT","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:06:11.727Z","englishUpdatedAt":"2026-10-15T18:35:35.108Z","reviewedAt":"2026-10-15T18:35:35.108Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"eb35747f7bce0212423bc22461e6dc00add278399a9c51364abfc021ea8cf73f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hat"},{"id":"ffe4868b-3fad-4891-9916-e5dd7e07e274","kind":"institutions","code":"UB-I5336","name":"拜耳","nameBasis":"transliterated","summary":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","description":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","country":null,"category":null,"originalName":"拜耳","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:56:24.319Z","englishUpdatedAt":"2026-10-15T18:26:25.264Z","reviewedAt":"2026-10-15T18:26:25.264Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5808cdf9b33bb071061d0b8562338a902031ad3ceedcff7d6f67a6b6f44de565","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Baier","path":"/institutions/baier"},{"id":"312897a5-5537-4b6e-a713-26964ffbdfb1","kind":"institutions","code":"UB-I5834","name":"日立创投","nameBasis":"transliterated","summary":"Rili Venture Capital is a Chinese venture capital firm, focused on investment in seed-, startup- and growth-stage startups.","description":"Rili Venture Capital is a Chinese venture capital firm, focused on investment in seed-, startup- and growth-stage startups.","country":null,"category":null,"originalName":"日立创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:28.414Z","englishUpdatedAt":"2026-10-15T18:26:24.780Z","reviewedAt":"2026-10-15T18:26:24.780Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0431c6b00a8c902e1f553d731bb6cc9d14d40fcdd3fc10fc3e3d9b49c0bd15de","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Rili Venture Capital","path":"/institutions/rili-venture-capital"}],"roundName":"Series D","amountLabel":"$80M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[{"id":"4f479724-386d-4eea-909c-b01eb45f4fda","kind":"institutions","code":"UB-I5349","name":"AstraZeneca","nameBasis":"original-brand","summary":"AstraZeneca is a company in the United States making strategic investments with industrial capital, investing in the equity of growth-stage and mature companies.","description":"AstraZeneca is a company in the United States making strategic investments with industrial capital, investing in the equity of growth-stage and mature companies.","country":null,"category":null,"originalName":"AstraZeneca","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:28.007Z","englishUpdatedAt":"2026-10-15T18:26:24.845Z","reviewedAt":"2026-10-15T18:26:24.845Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"eb446b300abaac4d78e9ef873e3ae0910304460169b04c6e113243d16fdd2f9a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/astrazeneca"},{"id":"7abed44d-c5e0-4c75-8240-bad977e0041d","kind":"institutions","code":"UB-I9978","name":"HAT","nameBasis":"original-brand","summary":"","description":"","country":null,"category":null,"originalName":"HAT","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:06:11.727Z","englishUpdatedAt":"2026-10-15T18:35:35.108Z","reviewedAt":"2026-10-15T18:35:35.108Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"eb35747f7bce0212423bc22461e6dc00add278399a9c51364abfc021ea8cf73f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hat"},{"id":"ffe4868b-3fad-4891-9916-e5dd7e07e274","kind":"institutions","code":"UB-I5336","name":"拜耳","nameBasis":"transliterated","summary":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","description":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","country":null,"category":null,"originalName":"拜耳","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:56:24.319Z","englishUpdatedAt":"2026-10-15T18:26:25.264Z","reviewedAt":"2026-10-15T18:26:25.264Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5808cdf9b33bb071061d0b8562338a902031ad3ceedcff7d6f67a6b6f44de565","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Baier","path":"/institutions/baier"},{"id":"312897a5-5537-4b6e-a713-26964ffbdfb1","kind":"institutions","code":"UB-I5834","name":"日立创投","nameBasis":"transliterated","summary":"Rili Venture Capital is a Chinese venture capital firm, focused on investment in seed-, startup- and growth-stage startups.","description":"Rili Venture Capital is a Chinese venture capital firm, focused on investment in seed-, startup- and growth-stage startups.","country":null,"category":null,"originalName":"日立创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:28.414Z","englishUpdatedAt":"2026-10-15T18:26:24.780Z","reviewedAt":"2026-10-15T18:26:24.780Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0431c6b00a8c902e1f553d731bb6cc9d14d40fcdd3fc10fc3e3d9b49c0bd15de","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Rili Venture Capital","path":"/institutions/rili-venture-capital"}],"path":"/companies/huma","structured":{"city":"Austin","country":"United States","location":null,"role":null,"category":null,"company":null},"definition":"Huma is a company in the Industry apps sector headquartered in Austin, United States, founded in 2011.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/huma"}